Search results - ORA - Oxford University Research Archive

1

Conference item

Germinal center expansion but not plasmablast differentiation is directly proportional to peptide-MHCII density via CD40-CD40L signaling strength

Jing, Z, McCarron, MJ, Dustin, ML, et al.
2022-05-01

2

Conference item

Role of autophagy in immune aging

Richter, F, Friedrich, M, Alsaleh, G, et al.
2021-08-25

3

Conference item

Itch as the major mediator of the effect of tofacitinib on health-related quality of life in PSA: a mediation analysis

Taylor, P, Bushmakin, AG, Cappelleri, JC, et al.
2020-06-02

4

Conference item

Prevalence and risk factors of hypertension among patients with X-linked hypophosphatemia

Maronga, C, Javaid, MK, Pinedo-Villanueva, R
2023

5

Conference item

A literature review of the healthcare resource use and productivity burden of X-linked hypophosphatemia

Pinedo Villanueva, R, Javaid, M, Williams, A, et al.
2023

6

Conference item

D-net: Siamese based network with mutual attention for volume alignment

Zheng, J-Q, Lim, NH, Papież, BW
2020-10-30

7

Conference item

Safety profile of baricitinib for the treatment of rheumatoid arthritis up to 9.3 years: an updated integrated safety analysis

Taylor, P, Takeuchi, T, Burmester, G, et al.
2022-07-01

8

Conference item

Assessing the relationship of patient global assessment of disease activity and health related quality of life by SF-36 with other patient-reported outcomes in rheumatoid arthritis: post hoc analyses of data from phase 3 trials of baricitinib

Strand, V, Sebba, A, Scardo, S, et al.
2022-07-01

9

Conference item

Concomitant use of statins in filgotinib-treated patients with rheumatoid arthritis

Taylor, PC, Charles-Schoeman, C, Alani, M, et al.
2021-05-19

10

Conference item

Minimal important change, patient acceptable symptom state, and treatment failure for the Oxford hip score in patients undergoing total hip arthroplasty: interpretation threshold values at 3-, 12-, and 24-month follow-up

Harris, LK, Ingelsrud, LH, Gromov, K, et al.
2022-04-01

11

Conference item

Minimal important change, patient acceptable symptom state, and treatment failure for the Oxford knee score in patients undergoing unicompartmental knee arthroplasty: interpretation threshold values at 3-, 12-, and 24-month follow-up

Harris, LK, Troelsen, A, Gromov, K, et al.
2022-04-01

12

Conference item

Valuation of lost productivity for individuals diagnosed with Osteogenesis imperfecta: follow-up findings from the Rudy Cohort Study in the UK

Cole, S, Javaid, M, Pinedo Villanueva, R
2022

13

Conference item

Evaluating the comparative effectiveness and safety of repurposed drugs for COVID-19

Tan, EH, Dawoud, D, Arshad, F, et al.
2022

14

Conference item

Investigating the impact of clustering by surgeon on trial conclusions: to adjust or not to adjust

Conroy, EJ, Blazeby, JM, Burnside, G, et al.
2022-10-03

15

Conference item

Investigating the presence of surgical learning in a randomised trial: the Timing of Primary Surgery for cleft palate (TOPS) trial

Conroy, EJ, Blazeby, JM, Burnside, G, et al.
2022

16

Conference item

Maturation of monocyte-derived DCs leads to increased cellular stiffness, higher membrane fluidity, and changed lipid composition

Luhr, JJ, Alex, N, Amon, L, et al.
2021-08-25

17

Conference item

Effects of the jak1-selective inhibitor filgotinib on gene expression profile in blood of patients with active rheumatoid

Conference abstract
Taylor, P, Tarrant, J, Zhao, L, et al.
2018-06-12

18

Conference item

Techniques for characterising long COVID in real world data

Kostka, K, Minty, E, Prieto-Alhambra, D, et al.
2022

19

Conference item

Evaluation of comorbidity patterns and identification of sub-groups in patients diagnosed with hip osteoarthritis in 94,720 patients from Spain

Pineda Moncusi, M, Strauss, VY, Robinson, DE, et al.
2022-05-23

20

Conference item

Can continuous knee pain outcome measures be harmonised?

Georgopoulos, V, Perry, TA, Smith, SL, et al.
2022-03-28

21

Conference item

3D superresolution microscopy on the immunological synapse at isotropic precision below 15 nm

Velas, L, Brameshuber, MO, Huppa, JB, et al.
2022-02-11

22

Conference item

Valuation of lost productivity for people with osteogenesis imperfecta: preliminary results from the RUDY cohort

Cole, SE, Javaid, M, Pinedo Villanueva, R
2022-10-25

23

Conference item

Whole blood transcriptional changes following selective inhibition of janus kinase 1 (JAK1) by filgotinib in MTX-naive adults with moderately-to-severely active rheumatoid arthritis (RA) (FINCH3)

Conference abstract
Taylor, PC, Downie, B, Elboudwarej, E, et al.
2020-06-01

24

Conference item

A supported lipid bilayer platform to study the impact of bi-specific engager architecture on T cell activation

Leithner, A, Kasturirangan, S, Dustin, ML
2021-08-25

25

Conference item

Physical therapies for DVT prophylaxis in surgical patients: a systematic review and evidence quality appraisal

Berner, JE, Geoghegan, L, Kyriazidis, I, et al.
2021-04-27

26

Conference item

PRMT5 inhibition reduces viability and stemness of pediatric high grade glioma

Brown, EJ, Balaguer-Lluna, L, Cribbs, A, et al.
2021-07-01

27

Conference item

Have people like me experienced a complication after primary THA?: Insights from an information tool based on registry data

Lübbeke, A, Cole, S, Fabiano, G, et al.
2022-06-24

28

Conference item

''Will I have to get my other hip replaced as well?'' Contralateral outcomes after hip arthroplasty from an information tool based on registry data

Pinedo-Villanueva, R, Fabiano, G, Cole, S, et al.
2022-06-22

29

Conference item

Have people like me experienced pain after their hip arthroplasty? Insights from DEdiCADE, an information tool based on registry data

Lübbeke Wolff, A, Cole, S, Fabiano, G, et al.
2022-06-22

30

Conference item

Unsupervised learning to understand patterns of comorbidity in 633,330 patients diagnosed with osteoarthritis

Pineda Moncusi, M, Strauss, VY, Robinson, DE, et al.
2022-02-24

31

Conference item

Pseudotime dynamics in pancreatic ductal adenocarcinoma reveal different mechanisms of hindrance in immunity through bifurcation of regulatory and cytotoxic T-cell differentiation

Jainarayanan, AK, Anand, NM, Arbe-Barnes, EH, et al.
2021-12-10

32

Conference item

Sex-specific challenges in patients with psoriatic arthritis (PsA): preliminary results from a systematic literature review (SLR)

Coates, LC, van der Horst-Bruinsma, IE, Lubrano, E, et al.
2021-09-01

33

Conference item

Does multimorbidity influence the outcomes of total hip replacement for osteoarthritis?

Ferguson, R, Prieto-Alhambra, D, Peat, G, et al.
2021-10-12

34

Conference item

Health partnership solidarity and adapting to challenges in AMCGP management of delayed presenting clubfoot project

Drury, G, Nunn, T, Lavy, C, et al.
2021-10-12

35

Conference item

Genome‐wide association study of varicose veins in 810,625 individuals identifies 45 genetic risk loci

Ahmed, WUR, Wiberg, A, Ng, M, et al.
2021-04-27

36

Conference item

Genome-wide association analysis In 401,583 individuals identifies novel therapeutic targets for haemorrhoids

Ahmed, WULR, Wiberg, A, Ng, M, et al.
2021-10-12

37

Conference item

Genome-wide association analysis and replication in 810,625 individuals identifies novel therapeutic targets for varicose veins

Ahmed, WULR, Wiberg, A, Ng, M, et al.
2021-10-12

38

Conference item

Evidence for the genetic influence of waist-hip ratio on risk of kidney stone disease

Lovegrove, C, Wiberg, A, Littlejohns, T, et al.
2021-07-08

39

Conference item

Biased calcium-sensing receptor signalling in the pathogenesis of kidney stone disease

Wiberg, A, Goldsworthy, M, Turney, BW, et al.
2021-06-01

40

Conference item

A data integration pipeline towards reliable monitoring of phytoplankton and early detection of harmful algal blooms

Guterres, B, Khalid, S, Pias, M, et al.
2022-04-01

41

Conference item

A first in disease phase 2A trial of granulocyte monocyte colony stimulating factor neutralisation for axial spondyloarthritis (NAMASTE study)

Al-Mossawi, MH, Worth, C, McDonald, J, et al.
2021-09-01

42

Conference item

Guselkumab provides sustained domain-specific and comprehensive efficacy as assessed using composite endpoints in patients with active psoriatic arthritis free

Coates, LC, Ritchlin, CT, Gossec, L, et al.
2021-05-19

43

Conference item

A hand exercises mHealth app for patients with rheumatoid arthritis: development, design and usability study in Turkey

Tonga, E, Srikesavan, C, Williamson, E, et al.
2020-06-02

44

Conference item

Guselkumab-treated patients with psoriatic arthritis achieved clinically meaningful improvements in general health outcomes measured with PROMIS-29 through 52 weeks: results from the phase 3 DISCOVER-1 trial

Orbai, AM, Coates, LC, Deodhar, A, et al.
2021-05-19

45

Conference item

The impact of COVID-19 on population-level drug utilization of alendronate

Tan, EH, Robinson, DE, Jödicke, A, et al.
2022-02-16

46

Conference item

Effect of filgotinib on pain in patients with rheumatoid arthritis: results from phase 3 clinical trials

Pope, J, Taylor, P, Kavanaugh, A, et al.
2021-07-01

47

Conference item

Baricitinib 4mg and 2mg once-daily reduced pain in both patients who were opioid users and non-users in active rheumatoid arthritis: a post-hoc analysis of phase 3 trials

Pope, J, Lee, Y, Curtis, J, et al.
2020-07-01

48

Conference item

Treatment patterns for osteoporosis medications in five European countries: a multinational real world cohort analysis

Robinson, DE, Tan, EH, Jödicke, A, et al.
2022-02-16

49

Conference item

Antibiotics use as a proxy for microbiome alteration and hip fracture risk: A population-based case-control study

Pascual-Dapena, APD, Prats-Uribe, APU, Prieto-Alhambra, D
2021-03-03

50

Conference item

Mode of administration in rheumatoid arthritis treatments: an exploration of patient preference for an 'ideal treatment'

Taylor, PC, Alten, R, Jesus Gomez-Reino, J, et al.
2016-11-08